<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>FOXM1, a member of the Forkhead Box (<z:e sem="disease" ids="C0016632" disease_type="Disease or Syndrome" abbrv="">Fox</z:e>) family of transcription factors, plays a critical role in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to elucidate its role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), particularly prognosis and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Semi-quantitative RT-PCR and Western blot assays were used to measure the expression levels of FOXM1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein in 15 CRC and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa tissues </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemical assay was performed to detect FOXM1 protein expression in 112 CRC tissues and further determine its clinicopathological and prognostic significance </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="40" ids="33697">RNA</z:chebi> interference (RNAi) was used to knockdown endogenous FOXM1 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines and to analyze the effects of FOXM1 knockdown on migration and invasion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>The relative expression levels of FOXM1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein were significantly higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues than in adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa tissues (P&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, the immunostaining of FOXM1 protein was stronger in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues than in adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa tissues </plain></SENT>
<SENT sid="7" pm="."><plain>By statistical analysis, we showed that high FOXM1 expression was closely correlated with the presence of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, incidence of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, and advanced TNM stage </plain></SENT>
<SENT sid="8" pm="."><plain>Moreover, the cumulative 5-year survival rate of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with high FOXM1 expression was lower than that of those with low FOXM1 expression (P=0.0047) </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate analysis showed that the status of FOXM1 expression was an independent prognostic factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients (P=0.025) </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, RNAi-mediated FOXM1 knockdown could significantly inhibit growth, migration and invasion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="11" pm="."><plain>Our results showed that FOXM1 over-expression is a molecular marker predicting increased invasive/metastatic potential of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and a poorer prognosis </plain></SENT>
</text></document>